Financial Snapshot

Revenue
$2.243B
TTM
Gross Margin
98.51%
TTM
Net Earnings
$385.9M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
436.72%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$2.719B
Q3 2024
Cash
Q3 2024
P/E
33.51
Nov 29, 2024 EST
Free Cash Flow
$440.1M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Revenue $1.887B $1.489B $1.134B $1.046B $788.1M $451.2M $161.6M $15.00M $19.77M $0.00 $2.919M $53.14M $77.41M $33.50M $3.000M $4.000M $1.200M $39.20M $123.9M $85.20M $139.1M $18.00M $41.20M $14.60M $16.80M $16.00M $26.10M $19.20M $6.100M $200.0K $0.00
YoY Change 26.76% 31.34% 8.38% 32.71% 74.67% 179.16% 977.51% -24.12% -100.0% -94.51% -31.36% 131.08% 1016.7% -25.0% 233.33% -96.94% -68.36% 45.42% -38.75% 672.78% -56.31% 182.19% -13.1% 5.0% -38.7% 35.94% 214.75% 2950.0%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Revenue $1.887B $1.489B $1.134B $1.046B $788.1M $451.2M $161.6M $15.00M $19.77M $0.00 $2.919M $53.14M $77.41M $33.50M $3.000M $4.000M $1.200M $39.20M $123.9M $85.20M $139.1M $18.00M $41.20M $14.60M $16.80M $16.00M $26.10M $19.20M $6.100M $200.0K $0.00
Cost Of Revenue $39.70M $23.20M $14.30M $10.10M $7.400M $4.889M $1.254M $0.00 $0.00
Gross Profit $1.847B $1.466B $1.119B $1.036B $780.7M $446.3M $160.4M $15.00M $19.77M
Gross Profit Margin 97.9% 98.44% 98.74% 99.03% 99.06% 98.92% 99.22% 100.0% 100.0%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Selling, General & Admin $887.6M $752.7M $583.3M $433.3M $354.1M $248.9M $169.9M $68.08M $32.48M $18.00M $13.30M $13.40M $12.50M $13.30M $14.40M $17.90M $35.40M $48.20M $42.30M $22.40M $20.60M $12.70M $10.90M $10.00M $7.500M $6.600M $5.700M $3.700M $2.700M $2.200M $1.600M
YoY Change 17.92% 29.04% 34.62% 22.37% 42.27% 46.49% 149.56% 109.61% 80.44% 35.34% -0.75% 7.2% -6.02% -7.64% -19.55% -49.44% -26.56% 13.95% 88.84% 8.74% 62.2% 16.51% 9.0% 33.33% 13.64% 15.79% 54.05% 37.04% 22.73% 37.5% 700.0%
% of Gross Profit 48.05% 51.36% 52.12% 41.83% 45.36% 55.77% 105.94% 453.87% 164.3%
Research & Development $565.0M $463.8M $105.3M $164.5M $154.3M $160.5M $121.8M $94.29M $81.49M $46.43M $39.25M $37.16M $30.95M $31.15M $33.70M $55.50M $77.10M $94.90M $106.6M $115.1M $177.3M $108.9M $74.30M $40.20M $29.20M $21.80M $18.80M $12.60M $7.700M $6.200M $2.800M
YoY Change 21.82% 340.46% -35.99% 6.61% -3.88% 31.76% 29.2% 15.71% 75.53% 18.29% 5.61% 20.07% -0.64% -7.56% -39.28% -28.02% -18.76% -10.98% -7.38% -35.08% 62.81% 46.57% 84.83% 37.67% 33.94% 15.96% 49.21% 63.64% 24.19% 121.43% 600.0%
% of Gross Profit 30.58% 31.65% 9.41% 15.88% 19.76% 35.97% 75.97% 628.61% 412.22%
Depreciation & Amortization $17.80M $15.10M $10.90M $8.600M $7.400M $4.000M $2.400M $1.500M $1.000M $800.0K $700.0K $700.0K $700.0K $1.400M $3.200M $7.600M $9.400M $10.60M $10.10M $7.100M $3.700M $3.100M $2.700M $2.200M $2.100M $1.700M $1.300M $1.000M $700.0K $500.0K $100.0K
YoY Change 17.88% 38.53% 26.74% 16.22% 85.0% 66.67% 60.0% 50.0% 25.0% 14.29% 0.0% 0.0% -50.0% -56.25% -57.89% -19.15% -11.32% 4.95% 42.25% 91.89% 19.35% 14.81% 22.73% 4.76% 23.53% 30.77% 30.0% 42.86% 40.0% 400.0%
% of Gross Profit 0.96% 1.03% 0.97% 0.83% 0.95% 0.9% 1.5% 10.0% 5.06%
Operating Expenses $1.453B $1.217B $1.031B $882.9M $715.8M $414.4M $293.0M $162.4M $114.0M $64.41M $52.60M $51.69M $43.49M $47.22M $48.10M $73.50M $112.6M $143.1M $149.0M $137.5M $197.9M $121.7M $85.10M $50.20M $36.60M $28.40M $24.40M $16.30M $10.50M $8.500M $4.400M
YoY Change 19.41% 17.99% 16.77% 23.34% 72.73% 41.44% 80.44% 42.47% 76.94% 22.46% 1.75% 18.86% -7.9% -1.82% -34.56% -34.72% -21.31% -3.96% 8.36% -30.52% 62.61% 43.01% 69.52% 37.16% 28.87% 16.39% 49.69% 55.24% 23.53% 93.18% 633.33%
Operating Profit $250.9M $249.0M $102.5M $163.0M $72.30M $36.80M -$131.4M -$147.4M -$94.20M -$64.41M -$49.68M $1.448M $33.92M -$13.72M
YoY Change 0.76% 142.93% -37.12% 125.45% 96.47% -128.01% -10.86% 56.44% 46.25% 29.66% -3530.8% -95.73% -347.21%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Interest Expense $4.600M $7.100M $25.80M $32.80M $32.00M $30.50M $19.52M $0.00 $0.00 $600.0K $400.0K $500.0K $400.0K $400.0K $700.0K -$4.900M $2.900M $6.800M $10.60M $8.900M $6.700M $6.000M $2.000M -$3.200M $2.800M $2.600M $800.0K $600.0K $100.0K
YoY Change -35.21% -72.48% -21.34% 2.5% 4.92% 56.23% -100.0% 50.0% -20.0% 25.0% 0.0% -42.86% -114.29% -57.35% -35.85% 19.1% 32.84% 11.67% 200.0% -162.5% -214.29% 7.69% 225.0% 33.33% 500.0%
% of Operating Profit 1.83% 2.85% 25.17% 20.12% 44.26% 82.88% 34.53% 1.18%
Other Income/Expense, Net $81.20M -$35.10M -$1.100M -$56.30M -$25.80M -$15.00M -$11.18M $6.282M $5.273M $3.869M $3.588M $3.577M $3.649M $5.754M $1.100M $0.00 $4.800M $6.600M -$100.0K $100.0K $200.0K $400.0K $1.000M $1.100M $500.0K $800.0K $600.0K $200.0K $0.00 $0.00
YoY Change -331.34% 3090.91% -98.05% 118.22% 72.0% 34.16% -277.98% 19.14% 36.29% 7.83% 0.31% -1.97% -36.58% 423.09% -100.0% -27.27% -200.0% -50.0% -50.0% -60.0% -9.09% 120.0% -37.5% 33.33% 200.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Pretax Income $332.1M $213.9M $101.4M $106.7M $46.50M $21.80M -$142.5M -$141.1M -$88.90M -$60.50M -$46.10M $5.000M $37.60M -$8.000M -$51.00M -$88.60M -$207.3M -$107.2M -$22.20M -$45.70M -$30.10M -$94.50M -$36.80M -$28.50M -$16.80M -$20.00M $5.300M $6.100M -$3.300M -$7.700M -$4.200M
YoY Change 55.26% 110.95% -4.97% 129.46% 113.3% -115.29% 1.03% 58.71% 46.94% 31.24% -1022.0% -86.7% -570.0% -84.31% -42.44% -57.26% 93.38% 382.88% -51.42% 51.83% -68.15% 156.79% 29.12% 69.64% -16.0% -477.36% -13.11% -284.85% -57.14% 83.33% 600.0%
Income Tax $82.40M $59.40M $11.80M -$300.6M $9.500M $700.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K $200.0K $0.00 $100.0K $300.0K $0.00 $0.00 $200.0K $200.0K $0.00 $0.00 $0.00
% Of Pretax Income 24.81% 27.77% 11.64% -281.72% 20.43% 3.21% 0.0% 0.0% 3.77% 3.28%
Net Earnings $249.7M $154.5M $89.60M $407.3M $37.00M $21.10M -$142.5M -$141.1M -$88.93M -$60.54M -$46.09M $5.025M $37.57M -$7.968M -$51.00M -$88.60M -$207.3M -$107.2M -$22.20M -$45.80M -$30.30M -$94.50M -$36.90M -$28.80M -$16.80M -$20.00M $5.100M $5.900M -$3.300M -$7.700M -$4.200M
YoY Change 61.62% 72.43% -78.0% 1000.81% 75.36% -114.8% 1.03% 58.65% 46.89% 31.36% -1017.21% -86.63% -571.52% -84.38% -42.44% -57.26% 93.38% 382.88% -51.53% 51.16% -67.94% 156.1% 28.13% 71.43% -16.0% -492.16% -13.56% -278.79% -57.14% 83.33% 600.0%
Net Earnings / Revenue 13.23% 10.38% 7.9% 38.94% 4.69% 4.68% -88.19% -940.6% -449.84% -1578.97% 9.46% 48.53% -23.78% -1700.0% -2215.0% -17275.0% -273.47% -17.92% -53.76% -21.78% -525.0% -89.56% -197.26% -100.0% -125.0% 19.54% 30.73% -54.1% -3850.0%
Basic Earnings Per Share $2.56 $1.61 $0.95 $4.38 $0.40 $0.23 -$1.62 -$1.63 -$1.05 -$0.81 -$0.69 $0.08 $0.68 -$0.15
Diluted Earnings Per Share $2.47 $1.56 $0.92 $4.16 $0.39 $0.22 -$1.62 -$1.63 -$1.05 -$0.81 -$0.69 $0.08 $0.67 -$0.15 -$1.304M -$2.307M -$5.455M -$2.844M -$603.3K -$1.265M -$935.2K -$3.098M -$1.419M -$1.303M -$879.6K -$1.105M $280.2K $366.5K -$282.1K -$706.4K -$688.5K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Cash & Short-Term Investments $1.032B $989.3M $711.3M $801.0M $670.5M $650.9M $515.9M $307.4M $379.2M $193.8M $145.7M $173.0M $129.1M $126.9M $53.50M $80.50M $179.4M $182.6M $273.1M $301.1M $453.2M $244.7M $320.0M $164.7M $91.10M $62.70M $75.10M $69.90M $18.70M $18.20M
YoY Change 4.28% 39.08% -11.2% 19.46% 3.01% 26.17% 67.83% -18.93% 95.67% 33.01% -15.78% 34.0% 1.73% 137.2% -33.54% -55.13% -1.75% -33.14% -9.3% -33.56% 85.21% -23.53% 94.29% 80.79% 45.3% -16.51% 7.44% 273.8% 2.75%
Cash & Equivalents $1.032B $262.9M $340.8M $187.1M $112.3M $141.7M $254.7M $83.30M $74.20M $31.00M $44.80M $63.80M $50.10M $54.10M $37.30M $68.50M $99.70M $81.00M $49.90M $61.00M $105.9M $44.30M $163.9M $21.10M $21.30M $11.70M $15.80M $11.30M $6.400M $4.700M
Short-Term Investments $780.5M $726.4M $370.5M $613.9M $558.2M $509.2M $261.2M $224.1M $305.0M $162.8M $101.0M $109.3M $79.00M $72.80M $16.10M $12.00M $79.70M $101.6M $223.1M $240.1M $347.3M $200.4M $156.1M $143.6M $69.80M $51.00M $59.30M $58.60M $12.30M $13.50M
Other Short-Term Assets $575.4M $79.10M $45.50M $30.10M $16.60M $18.60M $7.900M $3.100M $4.900M $4.400M $2.700M $2.200M $1.500M $1.700M $1.900M $900.0K $3.500M $3.900M $5.400M $4.500M $5.000M $3.100M $1.600M $1.800M $2.300M $1.600M $900.0K $800.0K $200.0K $300.0K
YoY Change 627.43% 73.85% 51.16% 81.33% -10.75% 135.44% 154.84% -36.73% 11.36% 62.96% 22.73% 46.67% -11.76% -10.53% 111.11% -74.29% -10.26% -27.78% 20.0% -10.0% 61.29% 93.75% -11.11% -21.74% 43.75% 77.78% 12.5% 300.0% -33.33%
Inventory $38.30M $35.10M $30.50M $28.00M $17.30M $10.90M
Prepaid Expenses
Receivables $439.3M $350.0M $185.5M $157.1M $126.6M $57.40M $31.10M $0.00 $14.10M $1.900M $4.500M $0.00 $0.00 $0.00 $7.200M $900.0K $8.200M $13.70M $200.0K $9.900M $6.000M $1.500M $1.400M $400.0K $1.300M $1.000M $0.00
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $1.607B $1.454B $972.8M $1.016B $831.0M $737.8M $554.9M $310.4M $384.1M $198.2M $148.5M $189.3M $132.5M $133.1M $55.40M $81.40M $182.9M $193.7M $279.3M $313.8M $471.8M $248.1M $331.5M $172.4M $94.80M $65.60M $76.40M $72.10M $19.90M $18.50M
YoY Change 10.56% 49.41% -4.27% 22.29% 12.63% 32.96% 78.77% -19.19% 93.79% 33.47% -21.55% 42.87% -0.45% 140.25% -31.94% -55.49% -5.58% -30.65% -10.99% -33.49% 90.17% -25.16% 92.29% 81.86% 44.51% -14.14% 5.96% 262.31% 7.57%
Property, Plant & Equipment $347.3M $145.6M $155.8M $127.4M $116.3M $33.90M $10.80M $6.300M $3.400M $2.500M $1.800M $1.900M $1.600M $1.500M $2.700M $6.200M $82.60M $91.40M $99.30M $102.2M $56.20M $14.10M $12.10M $11.30M $11.20M $10.90M $8.800M $3.500M $2.800M $2.700M
YoY Change 138.53% -6.55% 22.29% 9.54% 243.07% 213.89% 71.43% 85.29% 36.0% 38.89% -5.26% 18.75% 6.67% -44.44% -56.45% -92.49% -9.63% -7.96% -2.84% 81.85% 298.58% 16.53% 7.08% 0.89% 2.75% 23.86% 151.43% 25.0% 3.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $849.4M $401.5M $624.4M $265.3M $355.5M $216.0M $247.4M $43.50M $82.50M $37.50M $0.00 $500.0K $0.00 $3.700M $6.400M $21.10M $0.00 $1.400M $3.300M $0.00 $0.00 $0.00
YoY Change 111.56% -35.7% 135.36% -25.37% 64.58% -12.69% 468.74% -47.27% 120.0% -100.0% -100.0% -42.19% -69.67% -57.58%
Other Assets $412.2M $330.9M $319.5M $325.8M $3.200M $5.500M $4.500M $4.900M $4.800M $4.800M $4.400M $4.300M $4.300M $6.100M $6.300M $9.500M $11.10M $104.6M $104.5M $103.2M $26.90M $4.300M $2.600M $1.900M $2.600M $1.600M $2.200M $900.0K $400.0K $400.0K
YoY Change 24.57% 3.57% -1.93% 10081.25% -41.82% 22.22% -8.16% 2.08% 0.0% 9.09% 2.33% 0.0% -29.51% -3.17% -33.68% -14.41% -89.39% 0.1% 1.26% 283.64% 525.58% 65.38% 36.84% -26.92% 62.5% -27.27% 144.44% 125.0% 0.0%
Total Long-Term Assets $1.644B $915.2M $1.100B $718.5M $475.0M $255.4M $262.7M $54.70M $90.70M $44.80M $6.200M $6.700M $5.900M $11.30M $15.40M $36.80M $93.80M $196.0M $203.8M $205.4M $83.20M $18.40M $14.90M $13.60M $14.40M $14.90M $15.50M $5.900M $4.100M $3.800M
YoY Change 79.68% -16.78% 53.05% 51.26% 85.98% -2.78% 380.26% -39.69% 102.46% 622.58% -7.46% 13.56% -47.79% -26.62% -58.15% -60.77% -52.14% -3.83% -0.78% 146.88% 352.17% 23.49% 9.56% -5.56% -3.36% -3.87% 162.71% 43.9% 7.89%
Total Assets $3.251B $2.369B $2.073B $1.735B $1.306B $993.2M $817.6M $365.1M $474.8M $243.0M $154.7M $196.0M $138.4M $144.4M $70.80M $118.2M $276.7M $389.7M $483.1M $519.2M $555.0M $266.5M $346.4M $186.0M $109.2M $80.50M $91.90M $78.00M $24.00M $22.30M
YoY Change
Accounts Payable $318.3M $235.7M $142.8M $97.60M $46.20M $38.40M $5.600M $5.100M $2.600M $200.0K $100.0K $900.0K $1.100M $800.0K $2.200M $1.600M $3.800M $3.200M $3.400M $5.400M $1.300M $2.000M $1.500M $1.100M $2.400M $2.500M $1.800M $800.0K $800.0K $700.0K
YoY Change 35.04% 65.06% 46.31% 111.26% 20.31% 585.71% 9.8% 96.15% 1200.0% 100.0% -88.89% -18.18% 37.5% -63.64% 37.5% -57.89% 18.75% -5.88% -37.04% 315.38% -35.0% 33.33% 36.36% -54.17% -4.0% 38.89% 125.0% 0.0% 14.29%
Accrued Expenses $162.5M $129.3M $99.50M $81.40M $72.70M $34.40M $47.90M $21.10M $19.00M $11.50M $8.000M $8.100M $8.500M $8.600M $6.200M $10.90M $21.70M $12.40M $17.90M $19.80M $55.10M $22.20M $15.80M $11.10M $5.000M $2.100M $2.200M $1.400M $900.0K $600.0K
YoY Change 25.68% 29.95% 22.24% 11.97% 111.34% -28.18% 127.01% 11.05% 65.22% 43.75% -1.23% -4.71% -1.16% 38.71% -43.12% -49.77% 75.0% -30.73% -9.6% -64.07% 148.2% 40.51% 42.34% 122.0% 138.1% -4.55% 57.14% 55.56% 50.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $408.8M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $170.1M $169.4M $0.00 $1.500M $4.500M $5.800M $6.700M $4.000M $2.700M $2.100M $1.600M $1.000M $800.0K $900.0K $800.0K $700.0K $500.0K
YoY Change 0.41% -100.0% -66.67% -22.41% -13.43% 67.5% 48.15% 28.57% 31.25% 60.0% 25.0% -11.11% 12.5% 14.29% 40.0%
Total Short-Term Liabilities $654.8M $537.7M $245.8M $186.5M $565.3M $88.20M $54.40M $30.40M $25.70M $15.70M $11.70M $15.60M $47.10M $52.80M $20.00M $26.10M $29.90M $20.10M $33.70M $59.60M $110.0M $32.50M $24.80M $15.00M $8.600M $5.600M $7.000M $4.100M $2.900M $1.900M
YoY Change 21.78% 118.76% 31.8% -67.01% 540.93% 62.13% 78.95% 18.29% 63.69% 34.19% -25.0% -66.88% -10.8% 164.0% -23.37% -12.71% 48.76% -40.36% -43.46% -45.82% 238.46% 31.05% 65.33% 74.42% 53.57% -20.0% 70.73% 41.38% 52.63%
Long-Term Debt $0.00 $0.00 $335.1M $317.9M $0.00 $388.5M $369.6M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $108.7M $49.20M $53.60M $59.50M $32.50M $5.300M $3.600M $2.300M $2.100M $2.200M $700.0K $800.0K $1.600M $1.700M
YoY Change -100.0% 5.41% -100.0% 5.11% -100.0% 120.93% -8.21% -9.92% 83.08% 513.21% 47.22% 56.52% 9.52% -4.55% 214.29% -12.5% -50.0% -5.88%
Other Long-Term Liabilities $364.6M $123.2M $117.6M $104.1M $103.8M $35.70M $21.40M $19.80M $24.60M $18.70M $22.60M $26.00M $31.20M $72.30M $46.90M $55.30M $19.30M $5.700M $5.700M $6.400M $21.40M $4.500M $7.600M $5.500M $2.100M $800.0K $1.000M $300.0K $200.0K $0.00
YoY Change 195.94% 4.76% 12.97% 0.29% 190.76% 66.82% 8.08% -19.51% 31.55% -17.26% -13.08% -16.67% -56.85% 54.16% -15.19% 186.53% 238.6% 0.0% -10.94% -70.09% 375.56% -40.79% 38.18% 161.9% 162.5% -20.0% 233.33% 50.0%
Total Long-Term Liabilities $364.6M $123.2M $452.7M $422.0M $103.8M $424.2M $391.0M $19.80M $24.60M $18.70M $22.60M $26.00M $31.20M $72.30M $46.90M $55.30M $128.0M $54.90M $59.30M $65.90M $53.90M $9.800M $11.20M $7.800M $4.200M $3.000M $1.700M $1.100M $1.800M $1.700M
YoY Change 195.94% -72.79% 7.27% 306.55% -75.53% 8.49% 1874.75% -19.51% 31.55% -17.26% -13.08% -16.67% -56.85% 54.16% -15.19% -56.8% 133.15% -7.42% -10.02% 22.26% 450.0% -12.5% 43.59% 85.71% 40.0% 76.47% 54.55% -38.89% 5.88%
Total Liabilities $1.019B $660.9M $698.5M $608.5M $669.1M $512.4M $445.5M $50.20M $50.30M $34.30M $34.30M $41.60M $78.30M $125.1M $66.90M $81.40M $158.0M $75.00M $93.00M $125.4M $163.8M $42.30M $36.00M $22.80M $12.90M $8.600M $8.800M $5.200M $4.800M $3.600M
YoY Change 54.24% -5.38% 14.79% -9.06% 30.58% 15.02% 787.45% -0.2% 46.65% 0.0% -17.55% -46.87% -37.41% 87.0% -17.81% -48.48% 110.67% -19.35% -25.84% -23.44% 287.23% 17.5% 57.89% 76.74% 50.0% -2.27% 69.23% 8.33% 33.33%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $12.933 Billion

About NEUROCRINE BIOSCIENCES INC

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. The company is headquartered in San Diego, California and currently employs 1,700 full-time employees. The firm is engaged in discovering and developing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. Its diverse portfolio includes the United States Food and Drug Administration-approved treatments for tardive dyskinesia, chorea associated with Huntington’s disease, endometriosis and uterine fibroids, as well as a robust pipeline, including multiple compounds in mid-to late-phase clinical development across its core therapeutic areas. Its commercial products include INGREZZA, ALKINDI, EFMODY, Orilissa and Oriahnn. INGREZZA is marketed as DYSVAL (valbenazine) in Japan and REMLEAS (valbenazine) in other select Asian markets, where Mitsubishi Tanabe Pharma Corporation retains commercialization rights. ALKINDI is marketed as ALKINDI SPRINKLE (hydrocortisone) in the United States, where Eton Pharmaceuticals, Inc. retains commercialization rights.

Industry: Biological Products, (No Diagnostic Substances) Peers: ALNYLAM PHARMACEUTICALS, INC. Sarepta Therapeutics, Inc. Apellis Pharmaceuticals, Inc. Biohaven Pharmaceutical Holding Co Ltd. BIOMARIN PHARMACEUTICAL INC INCYTE CORP Karuna Therapeutics, Inc. Seagen Inc. UNITED THERAPEUTICS Corp